Literature DB >> 8913962

Cerebellar mutism after posterior cranial fossa surgery.

M Salvati1, L Cervoni, A Santoro.   

Abstract

Mutism is a rare sequel of PCF tumor removal. Three patients aged 5 to 20 years old with mutism after posterior fossa surgery are presented. Suboccipital craniectomy was performed in all patients with grossly total removal of a medulloblastoma. The mutism that may occur after an operation for a PCF lesion has been explained in functional and/or organic terms. To date, 24 similar cases of mutism following cerebellar operations have been reported in the literature. We review the features of the syndrome in the light of the published cases and speculate on the underlying physiopathology. The absence of long tract or other brain stem signs, together with a presence of dysarthria during the recovery of speech, suggested a organic cerebellar cause of the mutism.

Entities:  

Mesh:

Year:  1996        PMID: 8913962

Source DB:  PubMed          Journal:  J Neurosurg Sci        ISSN: 0390-5616            Impact factor:   2.279


  4 in total

Review 1.  Cause and outcome of cerebellar mutism: evidence from a systematic review.

Authors:  Rosa Reed-Berendt; Bob Phillips; Susan Picton; Paul Chumas; Daniel Warren; John H Livingston; Ellen Hughes; Matthew C H J Morrall
Journal:  Childs Nerv Syst       Date:  2014-01-23       Impact factor: 1.475

Review 2.  Postoperative posterior fossa syndrome: unraveling the etiology and underlying pathophysiology by using magnetic resonance imaging.

Authors:  Zoltan Patay
Journal:  Childs Nerv Syst       Date:  2015-07-05       Impact factor: 1.475

Review 3.  Cerebellar mutism: review of the literature.

Authors:  Thora Gudrunardottir; Astrid Sehested; Marianne Juhler; Kjeld Schmiegelow
Journal:  Childs Nerv Syst       Date:  2011-03       Impact factor: 1.475

4.  Rhesus macaque as an animal model for posterior fossa syndrome following tumor resection.

Authors:  Elena Buzunov; Jeffrey G Ojemann; Farrel R Robinson
Journal:  Pediatr Neurosurg       Date:  2010-07-20       Impact factor: 1.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.